digital health companies glp-1 weight loss Novo Nordisk seeks partners to boost GLP-1RA outcomes Market Overview: GLP-1 Agonists and

According to Grigson, Because our preliminary data suggested that patients did better in the study if they were on both the GLP-1 drug and medication for opioid use disorder, in this study, half of the participants will be on methadone and half will be on buprenorphine for opioid use disorder treatment. Because semaglutide is stronger, is dosed weekly instead of daily, and has fewer gastrointestinal side effects than liraglutide, it may be even more effective in reducing craving while increasing real-world treatment adherence

All of these studies are observational, meaning that their findings can't establish cause and effect

Abstract 4113997: Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease

(Nauck and Meier, 2016b)

Slowed Gastric Emptying : By slowing the rate at which the stomach empties food into the small intestine, GLP-1 medications prolong the sensation of fullness after eating